Experience

Surgify Medical Oy

• Finland
• Medical Device
• 1 - 100 Employee

• Chairman of the Board

  • Apr 2021 - Present

  Helsinki Metropolitan Area



ATRO Medical BV

• Netherlands
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Member of Supervisory Board

  • Jun 2017 - Present

  Oss, The Netherlands Being supportive in bringing a game-changer to the market: the "Trammpolin Medial Meniscus Implant".



LRG Leadership / LRG Management & Consulting

• Owner

  • May 2019 - Dec 2021

  Utrecht, Netherlands



JOHAN Sports

• Netherlands
• Spectator Sports
• 1 - 100 Employee

• Chairman Of The Board @ JOCRO Cooperatie U.A.

  • Apr 2016 - Jun 2020

  Naaldwijk, The Netherlands



ArthroSave B.V.

• Netherlands
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Chief Commercial Officer

  • Jun 2019 - Apr 2020

  Culemborg, Gelderland, Netherlands



Cabture BV

• Member Board of Directors Investeringcoöperatie Cabture U.A.

  • Apr 2016 - Jul 2017

  Amsterdam Area, Netherlands



Active Implants

• Israel
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Member Board of Directors

  • May 2013 - Apr 2017

  Memphis TN, USA

• President & COO

  • Jan 2012 - Jun 2016

  Driebergen, The Netherlands / Memphis TN, USA / Nethanya, Israel Bringing a game-changer to the market: the "NUsurface Meniscal Implant". Full corporate responsibility for all worldwide activities. Restructured offices in USA, Israel and The Netherlands. 25 FTE. Strategy and operational turnaround, securing $26M investment round at significant higher than anticipated pre-$ valuation. Revolutionary clinical and regulatory strategy, aiming for shortening FDA approval timelines by 6 years. 1 prospective single-arm, plus 1 RCT in multi-center sites in… Show more Bringing a game-changer to the market: the "NUsurface Meniscal Implant". Full corporate responsibility for all worldwide activities. Restructured offices in USA, Israel and The Netherlands. 25 FTE. Strategy and operational turnaround, securing $26M investment round at significant higher than anticipated pre-$ valuation. Revolutionary clinical and regulatory strategy, aiming for shortening FDA approval timelines by 6 years. 1 prospective single-arm, plus 1 RCT in multi-center sites in EU/Israel and 2 IDE-studies in USA. Heading for USA-FDA approval.



Joint Motion Technology

• CEO & President

  • Apr 2012 - Sep 2012

  Driebergen, The Netherlands



Pioneer Surgical Technology

• Vice-President EMEA & Business Development

  • Jan 2006 - Jan 2011

  Full P&L responsibility for (buildup of) all EMEA and China activities, as well as company-wide responsibility for overall business development. Consistently over-achieving budgets. 15 direct reports. Company was acquired by RTI Biologics Inc. in 2013



St. Francis Medical Technology (SFMT)

• Managing Director Europe & Business Development

  • Jan 2002 - Dec 2005

  The Netherlands / San Francisco An innovative Spine company, working on initiating new concepts in Spinal Surgery and bring these to the market. P&L responsibility for all activities in EMEA, Australia/New Zealand, as well as overall business development. Consistently over-achieving. From nil to double digit ($-)Million in ‘05. Market leader in key markets. 11 direct reports. www.sfmt.com. Company was acquired by Kyphon Inc. (currently Medtronic Inc.) for $725M in 2006.



Stryker

• United States
• Medical Equipment Manufacturing
• 700 & Above Employee

• Sales & Marketing Manager Europe

  • Nov 1995 - Jun 2001

  One of the most prestigious positions in Stryker Corporation, world’s leading orthopedic company, reporting to the VP Global Sales & Marketing and dotted line to the President of Stryker Biotech and the President, Chairman and CEO of Stryker Corporation (Mr. John Brown). Responsible for the introduction in Europe of one the most promising new biotech technologies in the orthopedic, trauma and spinal industry, the Recombinant Human Osteogenic Protein-1, rhOP-1, Bone Morphogenetic Protein-7… Show more One of the most prestigious positions in Stryker Corporation, world’s leading orthopedic company, reporting to the VP Global Sales & Marketing and dotted line to the President of Stryker Biotech and the President, Chairman and CEO of Stryker Corporation (Mr. John Brown). Responsible for the introduction in Europe of one the most promising new biotech technologies in the orthopedic, trauma and spinal industry, the Recombinant Human Osteogenic Protein-1, rhOP-1, Bone Morphogenetic Protein-7 or BMP-7 (,estimated market potential of > € 500 Million.) The full Sales & Marketing strategy and organizational structure for this pharmaceutical in the existing medical device environment, all the pre-marketing activities, including reimbursement, (pre-)clinical research, business development, education, OR-theatre training and extensive networking with leading customer groups were among my tasks, as well as close collaboration on management with all 12 local sales offices. The highest brand recognition among the surgical community in Europe was gained, as compared to the USA –home market for Stryker Biotech – as well as to main competitors with large European representation.

• Sales Manager Endoscopy & Instruments Benelux

  • Oct 1992 - Oct 1995

  In this position I was hired to build the (hardly existing) endoscopy business for Stryker in The Benelux. Starting on my own, growing this into a team of 8 sales reps. Growing sales from ~€ 75 K in 1992 to ~€ 4 M in 1995. In three years time Stryker achieved a position among the top 3 in the Benelux.